Sign Up Today and Learn More About ChromaCode Stock
Invest in or calculate the value of your shares in ChromaCode or other pre-IPO companies through EquityZen's platform.
ChromaCode Stock (CHRC)
ChromaCode is a molecular diagnostics company focusing on bioinformatics.
About ChromaCode Stock
Founded
2012
Headquarters
Carlsbad, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
ChromaCode Press Mentions
Stay in the know about the latest news on ChromaCode
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts, Strategies, Trends, Forecasts with Executive Guides
globenewswire • Nov 28, 2024
Earlier Detection and Treatment are Essential for Meeting VBC Goals
medcitynews • Nov 04, 2024
Systems, methods, and compositions for digital drop-off assays
patents • Apr 14, 2024
Methods, systems and compositions for detection of multiple analytes
patents • Apr 14, 2024
Fluorometric signal engineering for multiplexed qpcr
patents • Apr 14, 2024
ChromaCode Management
Leadership team at ChromaCode
Co-Founder & CTO
Aditya Rajagopal
Co-Founder
Axel Scherer
Join now and verify your accreditation status to gain access to:
- ChromaCode current valuation
- ChromaCode stock price
- Available deals in ChromaCode and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading ChromaCode Stock
How to invest in ChromaCode stock?
Accredited investors can buy pre-IPO stock in companies like ChromaCode through EquityZen funds. These investments are made available by existing ChromaCode shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ChromaCode stock?
Shareholders can sell their ChromaCode stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
